| abstract |
The present invention relates to novel compounds of formula (I), pharmaceutically acceptable salts, hydrates, solvates and isomers thereof, useful as inhibitors of Cyclin Dependent Kinase (hereinafter referred to as "CDK"). The present invention also relates to a method for preparing a compound of Formula 1 and an anticancer composition comprising a compound of Formula 1 as an active ingredient together with a pharmaceutically acceptable carrier.n n n n n n n n n n In the above formulan n n Y and Z are as defined in the specification. |